Dr. Michael R. Freedman, MD
- Part D claims, 2024
- 919
- Publications
- 1
- Industry payments
- $309
- Affiliated sites
- 2
- State license
- 1
- Practice address
- 4200 Pleasant Valley Road Suite B, Chantilly, VA 20151
- Practice phone
- Call (703) 222-2313
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Sunrise Medical Laboratories - Chantilly
Clinical Lab - Full Service · Chantilly, Virginia
Find Dr. Freedman's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael R. Freedman is an internist in Chantilly, Virginia
Dr. Freedman practices at Sunrise Medical Laboratories - Chantilly in Chantilly, Virginia.
Dr. Freedman's NPI, 1528045606, was assigned on December 29, 2005. Dr. Freedman holds Maryland license D0052245.
- NPI
- 1528045606NPI Registry (opens in a new tab)
- NPI enumeration date
- December 29, 2005
- NPI status
- Active
- Practice phone
- (703) 222-2313
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Michael R. Freedman practices at Sunrise Medical Laboratories - Chantilly in Chantilly, Virginia
Dr. Freedman's primary practice is Sunrise Medical Laboratories - Chantilly, at 4200 Pleasant Valley Road Suite B, Chantilly, VA 20151. The practice phone is (703) 222-2313.
- Sunrise Medical Laboratories - Chantilly4200 Pleasant Valley Road Suite B, Chantilly, VA 20151Phone(703) 222-2313
Source: Dmand AI Affiliation Data
Dr. Michael R. Freedman is affiliated with 2 sites of care
Dr. Freedman's primary practice is Sunrise Medical Laboratories - Chantilly in Chantilly, Virginia. Dmand AI also links Dr. Freedman to 1 physician office, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Michael R. Freedman's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Freedman practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Sunrise Medical Laboratories - Chantilly | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael R. Freedman is one of 3,339 internists in Virginia
Internal medicine is Dr. Freedman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Freedman is licensed in Maryland.
Specialties and state licenses
- Internal medicine, MarylandPrimary
Internists near Dr. Freedman
Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael R. Freedman's patients have a median age of 63
Across all payers, Dmand AI patient panel data puts Dr. Freedman's median patient age at 63, with 48% women.
Dr. Freedman's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 63
Patient panel by sex, all payers
- Women48%
- Men51%
Source: Dmand AI Patient Panel Data
Dr. Michael R. Freedman wrote 919 Medicare Part D claims in 2024
In 2024, Dr. Freedman wrote 919 Medicare Part D claims for 113 patients. 90% of them were for generic drugs. CMS names the drug for 547 of them, across 23 drugs with 11 or more claims each, at $37,839 in total drug cost. In 2023, CMS named 516 claims across 21 drugs.
Dr. Freedman's Part D claims by kind of drug, 2024
- Generic829 claims90%
- Brand-name and other90 claims10%
Dr. Freedman's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Freedman's Part D claims, 2024
- Opioids2%20 of 919 claims
- Antibiotics2%22 of 919 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5162024: 5476%
Drugs named by CMS: 23 in 2024, 21 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael R. Freedman has 1 publication on record
Dmand AI links 1 paper to Dr. Freedman in 2018.
Recent publications by Dr. Freedman
See who Dr. Freedman researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Freedman works with, so you can find a warm path to the right internists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael R. Freedman received $309 in industry payments from 2016 to 2024
CMS Open Payments shows 12 general payments to Dr. Freedman from 10 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Celgene Corporation paid the most, $131.
General payments to Dr. Freedman by program year, 2016 to 2024
Companies that paid Dr. Freedman the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Michael R. Freedman's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael R. Freedman
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael R. Freedman's NPI number?
Dr. Michael R. Freedman's NPI number is 1528045606. It was assigned on December 29, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael R. Freedman?
Dr. Michael R. Freedman is an internist in Chantilly, Virginia. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).
Where does Dr. Michael R. Freedman practice?
Dr. Freedman practices at 4200 Pleasant Valley Road Suite B, Chantilly, VA 20151. Dr. Freedman's primary practice is Sunrise Medical Laboratories - Chantilly in Chantilly, Virginia. Dmand AI also links Dr. Freedman to 1 physician office.
What is Dr. Michael R. Freedman's office phone number?
The practice phone on file for Dr. Freedman is (703) 222-2313.
What is Dr. Michael R. Freedman's medical license number?
Dr. Freedman holds Maryland license D0052245.
What drugs does Dr. Michael R. Freedman prescribe most?
In 2024 Medicare Part D data, Dr. Freedman's most prescribed drugs by claims were Atorvastatin Calcium, Amlodipine Besylate and Levothyroxine Sodium.
Has Dr. Michael R. Freedman received payments from drug or device companies?
CMS Open Payments shows $309 in general payments to Dr. Freedman from 10 companies from 2016 to 2024. The largest total came from Celgene Corporation.
How long has Dr. Michael R. Freedman been practicing?
Dr. Freedman's NPI was assigned in 2005.
Does Dr. Michael R. Freedman do research?
Dmand AI links 1 publication to Dr. Freedman.
Selling to internal medicine practices?
See internists in Virginia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card